Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Published in: Clinical & Experimental Metastasis 5/1999

01-07-1999

In vivo treatment of rats with unfractionated heparin (UFH) or low molecular weight heparin (LMWH) does not affect experimentally induced colon carcinoma metastasis

Authors: Susanne M. Smorenburg, Roel Vink, Merijn te Lintelo, Wikky Tigchelaar, Adrie Maas, Harry R. Büller, Cornelis J.F. van Noorden

Published in: Clinical & Experimental Metastasis | Issue 5/1999

Login to get access
Metadata
Title
In vivo treatment of rats with unfractionated heparin (UFH) or low molecular weight heparin (LMWH) does not affect experimentally induced colon carcinoma metastasis
Authors
Susanne M. Smorenburg
Roel Vink
Merijn te Lintelo
Wikky Tigchelaar
Adrie Maas
Harry R. Büller
Cornelis J.F. van Noorden
Publication date
01-07-1999
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 5/1999
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/A:1006648429914

Other articles of this Issue 5/1999

Clinical & Experimental Metastasis 5/1999 Go to the issue

OriginalPaper

A modified Boyden chamber assay for tumor cell transendothelial migration in vitro

OriginalPaper

Alterations in proteolytic activity at low pH and its association with invasion: A theoretical model

OriginalPaper

Quantitative detection of lac-Z-transfected CC531 colon carcinoma cells in an orthotopic rat liver metastasis model

OriginalPaper

Induction of c-met proto-oncogene expression at the metastatic site

OriginalPaper

Multi-organ metastatic capability of Chinese hamster ovary cells revealed by green fluorescent protein (GFP) expression

OriginalPaper

N-linked oligosaccharides and metastatic propensity in in vivo selected mouse mammary adenocarcinoma cells
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits